Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;2(8):592-596.

Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease

David T Rubin  1 , Sunana Sohi  1 , Rebecca A Shilling  2 , Steven R White  2
Affiliations

Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease

David T Rubin et al. Gastroenterol Hepatol (N Y). 2006 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chest radiograph showing bibasilar infiltrates: PA view (A) and lateral view (B).
Figure 2.
Figure 2.
Chest CT showing diffuse patchy nodular infiltrate in all lung fields with dense consolidation in the lower lobes.
Figure 3.
Figure 3.
Transbronchial biopsy sections showing interstitial and intra-alveolar eosinophilic infiltrates with giant cells and Charcot-Leyden crystals.
Figure 4.
Figure 4.
Chest radiograph at 3-month follow-up showed resolution of the pulmonary infiltrates: PA view (A) and lateral view (B).
See this image and copyright information in PMC

References

    1. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098–1104. - PubMed
    1. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy [Letter to editor] N Engl J Med. 2001;344:1099–1100. - PubMed
    1. Panagi S, Palka W, Korelitz B, et al. Diffuse alveolar hemorrhage after infliximab treatment of Crohn’s disease. Inflamm Bowel Dis. 2004;10:274–277. - PubMed
    1. Alrashid AI, Brown RD, Mihalov ML, et al. Crohn’s disease involving the lung: resolution with infliximab. Dig Dis Sci. 2001;46:1736–1739. - PubMed
    1. Gill KR, Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn’s disease [Letter to editor] Inflamm Bowel Dis. 2005;11:210–212. - PubMed

LinkOut - more resources